MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT00833833 · COMPLETED
Trial details
- NCT number
- NCT00833833
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.